• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Rare Blood

Latest News

hemophilia-jarun011-stock.adobe.com
Research Supports Need for Diversity in Hemophilia Trials and Reducing Resource Strain

December 24th 2024

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and improved diversity in clinical trials.

FDA-Deni-stock.adobe.com
First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA

December 23rd 2024

Top 5 Rare Blood
Top 5 Most-Read Articles on Rare Blood Disorders in 2024

December 20th 2024

There is a persistent unmet need for more effective therapies for hemophilia. Image credit: Mayava - stock.adobe.com.jpeg
Unmet Needs in Hemophilia: Prophylaxis, Bleeding, Quality of Life

December 12th 2024

Image of blood for hemophilia analysis-shidlovski-stock.adobe.com.jpeg
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data

December 11th 2024

More News

Working on gene therapy

Gene Transfer Therapy Requires Further Investigation Despite Potential Approval, Review Says

Larry Hanover
April 23rd 2021

After a more than 35-year pursuit, the licensing of a gene therapy product for treating hemophilia may be available within 2 years.

Read More

<1
...
34567
© 2025 MJH Life Sciences
AJMC®
All rights reserved.